Xylem consensus rating holds at Moderate Buy, shares trade around 112 dollars on NYSE
Published on 06/23/2026 at 16:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 16:00.
Xylem Inc. (US98419M1009) remains on analysts' radar with a consistent Moderate Buy consensus, according to fresh data from MarketBeat. The NYSE-listed water technology specialist most recently opened trading at 111.77 US dollars per share in New York, reflecting modest support from the sell-side community.
What the consensus data show
MarketBeat reports that thirteen brokerages currently cover Xylem, with the average recommendation classified as a Moderate Buy, underlining a broadly constructive but cautious stance among analysts. The same overview highlights that UBS Group in its April 29 research note set a neutral rating and lifted its price objective slightly from 132 to 133 US dollars, providing a reference point for upside potential against the current trading level. MarketBeat consensus report on Xylem
In the same analyst compilation, Xylem shares are cited with a recent opening quote of 111.77 US dollars on the NYSE, corresponding to an equity valuation of roughly 26.6 billion US dollars and a price-to-earnings ratio of 27.8. These figures position the stock in a premium bracket versus many traditional industrial peers, a point that often surfaces in sector comparisons when investors weigh water-technology exposure against other infrastructure or capital-goods names. Benzinga Xylem stock analysis snapshot
Tuesday focus on analyst stance
For Tuesday's trading picture, the consensus detail offers an important reference for investors following Xylem's path since its 2011 spin-off from ITT and its establishment as a standalone NYSE component. The Moderate Buy label combines several Buy ratings with a smaller number of Hold recommendations, illustrating a view that the stock still offers structural growth in water technology, while valuation metrics such as the 27.8 times earnings multiple indicate limited room for missteps. Extended MarketBeat coverage of XYL
Sector comparisons regularly include peers like Danaher, Ecolab or Pentair, which also operate in advanced fluid handling, testing or treatment solutions, though each with different mix and margin profiles. Xylem's 1.05 beta as noted in the analyst data suggests a risk profile broadly in line with the wider equity market, an element that can be relevant when investors balance defensive water exposure with overall volatility in diversified portfolios. MarketWatch quote and peer overview for Xylem
All news and analysis on the Xylem shares
Further company reports, consensus updates and regulatory filings on Xylem are compiled in the dedicated topic section on ad-hoc-news.de and the company investor-relations pages.
How Xylem earns its money
Xylem generates its revenue by providing water technology solutions across the utility, industrial, commercial and residential segments, ranging from pumps and filtration systems to advanced analytics and measurement devices. A core example is its Flygt-branded submersible pump line, which is used worldwide in municipal wastewater networks and industrial applications to move and manage large volumes of water efficiently.
Where the shares trade today
The Xylem shares (US98419M1009) most recently opened trading on the NYSE at 111.77 US dollars on the referenced Tuesday session, with that price level also forming the basis for the current market-capitalization data cited in recent analyst and market reports.
Key data on the Xylem shares
- Company: Xylem Inc.
- ISIN: US98419M1009
- WKN: A1JMBU
- Ticker: XYL
- Trading venue: NYSE
- Price (as of 2026-06-23, 15:30): 111.77 US dollars
- Market cap: 26.57 billion US dollars (as of 2026-06-23)
- Sector / industry: Industrials / Water Technology
- Index membership: S&P 500
- Next earnings date: 2026-07-30
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of an offer to buy or sell securities. All data points are based on sources cited in the text and may change over time.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
